An Alternative to Within3: Choosing the Right Engagement Platform in 2026

The ExtendMed difference

When I founded ExtendMed, I drew on 20+ years of experience simplifying medical education and training solutions for med comms agencies, medical associations and pharma companies. I understood the challenges small to mid-size life science companies face because I'd lived them. I knew how hard it could be for a small team with limited resources to engage KOLs, convene advisory boards, build education programs and develop speaker bureaus. That's why we designed ExtendMed the way we did.

Our platform helps medical affairs and commercial teams, and the agencies they work with, select and adapt corporate assets to local needs. The result: more frequent and more valuable interactions at a third of the cost of traditional approaches.

The workflow problem nobody talks about

Here's what we see with most teams that come to us, whether from Within3 or from a patchwork of tools: they're running a hybrid advisory board across four or five systems. Within3 or a discussion platform for async. Zoom or Teams for the live sessions. Otter.ai for transcription. SharePoint or Google Docs for the consensus document. Email for everything in between.

Each tool has its own login, its own data silo and its own compliance footprint.

• Context gets lost at every handoff.

• The insights from the live session don't connect to the async discussion.

• The transcription misspells half the drug names.

• The consensus document lives in a completely separate system from the discussion that generated it.

ExtendMed runs sync meetings, async discussions, audit-grade medical transcription and document collaboration in one platform. One login for your advisors. One system of record for your team. That's a workflow argument, not a feature argument. And workflow arguments hold up better in procurement.

Worth asking in your next vendor evaluation: When you run a hybrid board today, how many tools does your team have to coordinate, and where does context get lost?

The organizations that see the most value from working with us

Typically, teams that get the most from ExtendMed:

• Are looking for a smaller partner that can provide both senior-level healthcare technology guidance and flexible software
• Need a solution without a long-term contract requirement
• Want a customizable platform, not a rigid SaaS product
• Need to consolidate data from advisory boards, surveys and discussions into one place
• Want dedicated virtual advisory board hosting software
• Are running hybrid boards and tired of coordinating multiple tools

One platform for sync, async, transcription and collaboration

Within3 is built around asynchronous discussions. For certain use cases, that's enough. But most advisory boards need both live and async components. And when those run in separate systems, your team ends up coordinating Within3 for the discussions, Zoom for the live session, Otter for the transcript and SharePoint for the follow-up document. That's four tools and four places where context falls through.

We built ExtendMed to run all of those engagement modes in one platform: surveys, synchronous meetings, threaded discussions and document collaboration.

We find that async and sync are not substitutes for each other; they're complements.

• Asynchronous gives participants flexibility. Some advisors prefer engaging first thing in the morning.

• Others prefer midnight. But there's real value in getting people together in a live virtual session where they react to one another in real time.

• A live session builds rapport and surfaces initial reactions.

• Async follow-up gives advisors time to think and respond with more depth. When both happen in the same system, the insights connect. When they happen across four tools, they don't.

Here's a look at some of our engagement modalities:

Community pages enable stakeholders to learn about each other by sharing bios, patient cases, communications and more.

Integrated virtual and onsite meetings offer synchronous engagements. We help orchestrate and support the logistics of your planned events with the right balance of audience interactivity and content sharing.

Discussion boards target specific community members for comment, solicit insights on various planned topics, support threaded discussion and conversation between peers and cultivate stakeholder relationships and loyalty.

Questionnaires, assessments and quizzes support quantitative analysis with deep qualitative insights.

In the videos below, I quickly walk through the engagement tools we use for managing speaker programs and engaging thought leaders at national congresses—two example use cases of our Health Expert Connect™ platform that illustrate our multi-modal engagement capabilities.

We've heard from former Within3 clients that they often found themselves needing something specific, like a virtual advisory board, only to be steered toward a more general "expert insights" approach. We give you the tools for the job you actually need: a quick survey, a live virtual meeting, an extended asynchronous discussion, or all three combined.

Discussion boards work well when your team has something to review after a virtual meeting. Advisors can review materials and comment back and forth over a set time window, say one to three weeks. A moderator probes deeper, highlights key points and draws connections between different advisors' comments. That combination, and the way we run it all in one system, is what sets us apart from Within3.

Medical transcription, not generic transcription

This is something teams don't think about until it costs them hours of cleanup.

Generic transcription tools like Otter.ai and Zoom's built-in transcription are trained on business English. They handle "quarterly revenue" fine. They do not handle monoclonal antibody names, mechanism-of-action terminology or clinical endpoint language. Your team gets a transcript full of misspellings and garbled medical terms that someone has to manually correct before it's usable for reporting or compliance documentation.

Our platform generates audit-grade medical transcription built for therapeutic-area terminology. The transcript is tied directly to the meeting record, the discussion thread and the advisor profile, all in one system. No exporting. No cleanup. No reconciling a transcript in one tool against notes in another.

Worth asking in your next vendor evaluation: What's your transcription accuracy on therapeutic-area-specific terminology, and how do you verify it?

What happens after the advisory board ends

Most advisory boards produce a consensus document, summary report or set of strategic recommendations. In a typical setup, someone exports the discussion notes and transcript into Word or Google Docs, emails it to the advisory panel and manages a separate review process. Version control breaks down. The connection between the original discussion and the final document disappears.

ExtendMed supports real-time document collaboration inside the platform. Advisors can co-author documents, leave inline comments and review each other's contributions with timestamps and full version history. The work stays connected to the discussion and meeting that generated it, which matters for audit trails and for maintaining the thread of reasoning from initial insight to final recommendation.

Worth asking in your next vendor evaluation: If your advisors need to co-author a consensus document after the board, where does that work happen?

Flexible contracts and white-glove service

We don't lock clients into long, rigid contracts. We've learned that's standard for Within3, and it makes sense for their enterprise client base. But it doesn't work for everyone.

We offer project-based engagements. Start with a 6-month pilot. Run a short-term steering committee engagement. Test the platform on one project before scaling. Our approach lets you evaluate effectiveness without a year-long minimum commitment.

We also provide white-glove service because small and mid-size teams need it. You don't just get a tool. You get a dedicated senior program manager who provides strategic support and hands-on guidance. We've heard from former Within3 clients that as that company grew, they experienced inconsistent service and less personal attention. At ExtendMed, that level of service is built into every engagement.

We recently helped Mediar Therapeutics, a former Within3 customer, implement a more flexible solution for a virtual advisory board that combined both synchronous and asynchronous methods. You can read more about this in our Mediar case study.

ExtendMed vs. Within3: a detailed comparison

1. Target market and company focus

Within3 has built its reputation serving the largest players in pharma. They provide global, enterprise-level solutions for companies with extensive resources and a defined need for asynchronous engagement. If you're a large organization with over 1,000 employees or $500M+ in revenue, with operations spanning multiple countries, Within3 might make sense.

But if you're a small to mid-size company? Maybe fewer than 500 employees, under $250M in revenue, or growing fast and needing a partner that can start small? That's where ExtendMed works best. We built Health Expert Connect for companies like yours, because we understand the constraints that come with a lean team and limited resources.

2. Why engagement mode flexibility changes the buying decision

Within3 built its name on asynchronous engagement: global discussions and time-shifted interactions. That works well if most of your engagements are async and involve stakeholders across multiple time zones.

But most companies need more than that. We've developed an approach that combines sync and async in one platform: virtual advisory board hosting, live video meetings and real-time surveys alongside discussion boards and time-shifted surveys. You can run a live meeting, shift to async for deeper analysis and come back for a closing session without switching tools.

The flexibility to mix formats within a single engagement, rather than being limited to one approach, tends to produce richer insights and stronger advisor relationships.

And engagement mode is only half the story. The other half is whether all those modes run in one system. If your sync meetings happen in Zoom, your async discussions happen in Within3 and your post-board collaboration happens in SharePoint, you're not getting the benefit of multimodal engagement. You're getting the overhead of multimodal coordination.

3. Platform economics without enterprise minimums

Within3 typically requires year-long minimum commitments with pricing that reflects an enterprise SaaS model. That makes sense for their core market: the largest pharma companies running continuous global programs. But for a mid-market biotech preparing two advisory boards and a steering committee, enterprise pricing and annual contracts don't fit.

We offer short-term pilots starting at $20,000–$25,000, so you can test the platform before making a larger commitment. For more extensive programs, like year-long multi-panel engagements, projects typically run around $100,000.

We also don't charge enterprise minimums. If you need one advisory board to start, you can run one advisory board. Grow at your own pace.

4. Service and support

The level of support you get can determine whether a platform actually works for your team.

Within3 operates on a standard SaaS model with the typical enterprise support features. That can be sufficient if you have an experienced internal team managing the platform day to day.

At ExtendMed, each client is assigned a dedicated senior-level healthcare technology expert as a program manager. These managers provide hands-on support for platform customization and engagement strategy, not just technical troubleshooting. We're an extension of your team.

When Mediar Therapeutics needed a specific feature during their advisory board, we developed and shipped it in less than a week. That kind of responsiveness is difficult to get from a large-scale SaaS vendor.

5. Customization

Within3 runs a standardized SaaS model. Consistency is the tradeoff for scale.

ExtendMed is built to be customized. We adapt the platform to your SOPs, branding and workflow preferences. During our work with Mediar Therapeutics, Dr. Jeffrey Bornstein needed the ability to send targeted questions to specific subsets of advisors during the asynchronous discussions. We built and deployed that feature in under a week.

We didn't stop there! We also added capabilities for moderators to pose follow-up questions, highlight key points and draw connections between different advisors' comments. Those improvements went out to all clients. It's not about having every possible feature from day one. It's about being able to build what you need, fast, when you need it.

For agencies and companies working with them

If you're a pharma company working with a med comms agency, here's something worth knowing: your agency is probably coordinating four or five tools to run your advisory boards. Zoom for the meeting. Survey Monkey for the questionnaire. Email for follow-up. SharePoint for document review. Your team is paying agency rates for all of that coordination.

ExtendMed is the platform your agency runs the board on, without you paying agency margin on the technology.

Here's how it usually works. Your agency creates strong content and knows your disease area cold. But when it comes to distributing that content, collecting structured feedback and tracking engagement across modalities, they're stitching together tools that weren't designed to work together. Meetings on one platform. Surveys on another. Insights end up siloed. The agency spends hours reconciling data across systems, and you're paying for that time.

We fill that gap. We don't replace your med comms agency. We complement their content expertise with the engagement tools and analysis capabilities they need to do their work more efficiently. We bring unique efficiencies in producing content across formats and running the engagements, all at a fraction of the cost and complexity of traditional approaches.

For agencies reading this: we're not competing with you for the content work. You bring the disease-area expertise, the messaging strategy and the moderation. We bring the platform. That positions ExtendMed as a partner to the agency layer rather than a competitor, and it opens a real channel for both sides.

Our goal isn't to replace what agencies do best. We free their teams to focus on content and strategy by providing the engagement platform that delivers outcomes faster and more reliably. By partnering with ExtendMed, agencies offer their clients a complete solution, their expertise plus our technology, without building or maintaining their own platform.

Ready to see the difference?

If your team is running advisory boards across four or five tools, or paying enterprise prices for a platform that doesn't fit your organization's size, we should talk.

ExtendMed gives you sync meetings, async discussions, medical transcription and document collaboration in one platform. Senior moderation. Audit-grade compliance. No enterprise minimums.

Read our Mediar Therapeutics case study to see how we helped a former Within3 customer implement a more flexible, cost-effective solution. Learn more about ExtendMed vs. Within3, and contact us to schedule a demo.